THE HOPE. “If systems biology can rise to the challenge of predicting the mutations that are most likely to allow a cancer to relapse, we may be able to design multi-drug treatments that will prevent cancers from evading conventional drug treatments.”
https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022